Qianmei Yang

First People's Hospital of Chongqing — China

Medicine · Health Sciences

10h-index667citations19works0.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(4), Cancer Research and Treatments(4), Immunotherapy and Immune Responses(3), Cellular transport and secretion(3), Nanoplatforms for cancer theranostics(3)

Publications19 total

Correction: Bacteria‑triggered liposomes for synergistic tumour therapy based on the hypoxic microenvironment
Cancer Nanotechnology·2026Open Access
Correction: Bacteria-triggered liposomes for synergistic tumour therapy based on the hypoxic microenvironment
Cancer Nanotechnology·2025Open Access
Bacteria-triggered liposomes for synergistic tumour therapy based on the hypoxic microenvironment
Cancer Nanotechnology·2025· 1 citedOpen Access
Construction of risk prediction model of sentinel lymph node metastasis in breast cancer patients based on machine learning algorithm
Discover Oncology·2025· 1 citedOpen Access
Bioinformatics analysis and validation of genes related to paclitaxel's anti-breast cancer effect through immunogenic cell death
Heliyon·2024· 1 citedOpen Access
Speed and Power Tradeoff Based on FinFET Structure, Voltage Changing and Circuit Layout
2022 IEEE 5th International Conference on Automation, Electronics and Electrical Engineering (AUTEEE)·2022
SNAT7 regulates mTORC1 via macropinocytosis
Proceedings of the National Academy of Sciences·2022· 21 citedOpen Access
ArfGAP1 inhibits mTORC1 lysosomal localization and activation
The EMBO Journal·2021· 33 citedOpen Access
Correction: IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis
The Journal of Immunology·2020· 2 citedOpen Access
Glutamine and asparagine activate mTORC1 independently of Rag GTPases
Journal of Biological Chemistry·2020· 212 citedOpen Access
Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy
Theranostics·2020· 71 citedOpen Access
A Novel Antitumor Strategy: Simultaneously Inhibiting Angiogenesis and Complement by Targeting VEGFA/PIGF and C3b/C4b
Molecular Therapy — Oncolytics·2019· 26 citedOpen Access
Author Correction: A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity
Signal Transduction and Targeted Therapy·2019· 2 citedOpen Access
Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy
Molecular Therapy·2018· 111 citedOpen Access
Follistatin‐like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase‐dependent apoptosis and regulating Bcl‐2 family proteins
Journal of Cellular and Molecular Medicine·2018· 26 citedOpen Access
A Web-Based Platform for Segmentation of Abdominal Organs on CT Images
IFIP advances in information and communication technology·2018Open Access
<scp>DDA</scp>1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle
Journal of Cellular and Molecular Medicine·2017· 19 citedOpen Access
A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity
Signal Transduction and Targeted Therapy·2016· 49 citedOpen Access
IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis
The Journal of Immunology·2016· 92 cited

Frequent Co-authors

Dechao Yu(9), Hongxin Deng(9), Yuquan Wei(8), Lin Cheng(6), Lei Dai(6), Shuang Zhang(5), Chunlei Li(5), Gang Shi(5), Rong Xiang(5), Yujing Zhang(4), Yi Lin(4), Qingnan Wang(4), Xiaolan Su(4), Yang Yang(4), Delong Meng(3), Chase H. Melick(3), Jenna L. Jewell(3), Junfeng Zhang(3), Yiming Li(3), Huiling Wang(3)